Literature DB >> 15233693

How effective are the usual treatments for ulcerative colitis?

J R Bebb1, B B Scott.   

Abstract

BACKGROUND: Details of the efficacy of the drugs used in ulcerative colitis are not readily available.
METHODS: We have reviewed all placebo-controlled trials of the commonly used drugs for both induction and maintenance of remission to determine the efficacy and to calculate the numbers needed to treat (NNTs) to achieve a specified benefit for each drug.
RESULTS: The drug response rates and the NNTs (with 95% CI) are tabulated for each drug.
CONCLUSION: Corticosteroids give a remission rate of 68% in mild or moderate disease and an NNT for remission of 2 (95% CI 1.4-5) in mild disease. Intravenous hydrocortisone gives a remission rate of 60-73%. Aminosalicylates are relatively ineffective in inducing remission with an NNT of 10 (95% CI 7-21) improving to 8 (95% CI 5-20) if the dose > or = 3 g daily. They are better at maintenance (NNT = 6; 95% CI 4-8). Intravenous ciclosporin is very effective in achieving remission in severe colitis with an NNT of 1.2 (95% CI 1-2.5). Although there is fairly good evidence that azathioprine is effective in maintaining remission and is used widely, there are no suitable placebo-controlled trials to calculate the NNT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15233693     DOI: 10.1111/j.1365-2036.2004.02018.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  9 in total

Review 1.  Advances in therapeutic approaches to ulcerative colitis and Crohn's disease.

Authors:  Simon Travis
Journal:  Curr Gastroenterol Rep       Date:  2005-12

2.  Point-counterpoint: Are we overtreating patients with mild ulcerative colitis?

Authors:  Akbar K Waljee; Ryan W Stidham; Peter D R Higgins; Sandeep Vijan; Sameer D Saini
Journal:  J Crohns Colitis       Date:  2013-08-12       Impact factor: 9.071

Review 3.  Budesonide for the treatment of ulcerative colitis.

Authors:  Maisa I Abdalla; Hans Herfarth
Journal:  Expert Opin Pharmacother       Date:  2016-06-16       Impact factor: 3.889

Review 4.  Current treatment of ulcerative colitis.

Authors:  Johannes Meier; Andreas Sturm
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

5.  Leukocytapheresis: An "Out-of-Body" Experience in Inflammatory Bowel Disease.

Authors:  Seymour Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-12

6.  Clinical manifestations and outcomes in severe ulcerative colitis.

Authors:  Xuesong Yang; Wei Yao; Wenbin Liu; Jun Li; Yumin Lu
Journal:  Front Med China       Date:  2007-05

Review 7.  Emerging drugs for the treatment of ulcerative colitis.

Authors:  Luca Pastorelli; Theresa T Pizarro; Fabio Cominelli; Maurizio Vecchi
Journal:  Expert Opin Emerg Drugs       Date:  2009-09       Impact factor: 4.191

8.  Relapse Prevention in Ulcerative Colitis by Plant-Based Diet Through Educational Hospitalization: A Single-Group Trial.

Authors:  Mitsuro Chiba; Kunio Nakane; Tsuyotoshi Tsuji; Satoko Tsuda; Hajime Ishii; Hideo Ohno; Kenta Watanabe; Mai Ito; Masafumi Komatsu; Koko Yamada; Takeshi Sugawara
Journal:  Perm J       Date:  2018

Review 9.  Second Korean guidelines for the management of ulcerative colitis.

Authors:  Chang Hwan Choi; Won Moon; You Sun Kim; Eun Soo Kim; Bo-In Lee; Yunho Jung; Yong Sik Yoon; Heeyoung Lee; Dong Il Park; Dong Soo Han
Journal:  Intest Res       Date:  2017-01-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.